dermatology
Digital/ News/ News/ News/ Patients
Almirall-backed psoriasis support app Claro launches in Europe
Phil Taylor
Almirall, dermatology, digital, digital health, Happify, mental health, patient support, psoriasis
0 Comment
News/ News/ Sales and Marketing
FDA grants speedy review to Dupixent rare skin disease
Phil Taylor
dermatology, Dupixent, prurigo nodularis, rare disease, Regeneron, regulatory, Sanofi
0 Comment
Third FDA rejection for Verrica’s molluscum contagiosum drug
Phil Taylor
dermatology, drug devices, infectious disease, molluscum contagiosum, Verrica Pharmaceuticals, VP-102
0 Comment
Dermavant claims its first approval as FDA clears psoriasis drug
Phil Taylor
dermatology, Dermavant, psoriasis, regulatory approval, tapinarof, Vtama
0 Comment
Sidekick and Pfizer prep launch of DTx for atopic dermatitis
Phil Taylor
atopic dermatitis, dermatology, digital, digital health, digital therapeutics, Pfizer, Sidekick Health
0 Comment
Happify says study backs value of its wellbeing app in psoriasis
Phil Taylor
app, dermatology, digital, digital health, Happify, mental health, psoriasis
0 Comment
FDA turns down Amryt’s epidermolysis bullosa drug
Phil Taylor
Amryt Pharma, dermatology, epidermolysis bullosa, inherited disease, rare disease, regulatory
0 Comment